Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Diabetologia|November 15, 2005
Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)H M Colhoun, D J Betteridge, P N Durrington, et al.
Faraday Discussions|April 16, 2015
Self-association of organic solutes in solution: a NEXAFS study of aqueous imidazoleM J Thomason, C R Seabourne, B M Sattelle, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 22, 2013
Asthma phenotypes identified by latent class analysis in the ISAAC phase II Spain studyG Weinmayr, F Keller, A Kleiner, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2002
Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetesH M Colhoun, M J Thomason, M I Mackness, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetesM J Thomason, H M Colhoun, S J Livingstone, et al.
The British Journal of Dermatology|October 11, 2019
Longitudinal analysis of the effect of water hardness on atopic eczema: evidence for gene-environment interactionZ K Jabbar-Lopez, J Craven, K Logan, et al.
The European Respiratory Journal|June 27, 2008
International variation in prevalence of rhinitis and its relationship with sensitisation to perennial and seasonal allergensG Weinmayr, F Forastiere, S K Weiland, et al.
Atherosclerosis|June 24, 2003
The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart diseaseS S Soedamah-Muthu, H M Colhoun, M J Thomason, et al.
Gut|January 21, 2006
Lack of association of MYO9B genetic variants with coeliac disease in a British cohortK A Hunt, A J Monsuur, W L McArdle, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 15, 2020
Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trialD T Wademan, L Busakwe, T J Nicholson, et al.
Pageof 16